Matrix metalloproteinase-2 - The forgotten enzyme in aneurysm pathogenesis

被引:34
|
作者
Thompson, Matt [1 ]
Cockerill, Gillian [1 ]
机构
[1] St George Hosp, Dept Vasc Surg, St Georges Vasc Inst & Acad, London SW17 0RE, England
关键词
metalloproteinase; MMP-2; elastolysis;
D O I
10.1196/annals.1383.034
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The pathogenesis of abdominal aortic aneurysm (AAAs) involves progressive cycles of proteolysis and inflammation, the product of proteolysis driving subsequent inflammation. Little is yet known about the initiating events. We review the specific literature examining the possibility that MMP-2 may be the initial catalyst. Histologically, elastolysis is one of the earliest observable events in aneurysm genesis. Matrix metalloproteinase-2 (MMP-2), as the dominant gelatinase differentially expressed in aneurysmal tissue and cells derived from aneurysms, would be a good candidate. We report the results of in vivo and in vitro experiments, which lend support to the importance of MMP-2 as an aneurysmal initiator.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 50 条
  • [31] Matrix metalloproteinase-2 promoter variability in psoriasis
    Vladimir Vasku
    Julie Bienertova Vasku
    Veronika Slonková
    Kateřina Kaňková
    Anna Vasku
    Archives of Dermatological Research, 2009, 301 : 467 - 473
  • [32] Matrix metalloproteinase-2 and mesangiolysis in diabetic nephropathy
    Kanauchi, M
    Nishioka, H
    Kawano, T
    Uyama, H
    Shiiki, H
    Dohi, K
    NEPHRON, 1999, 83 (02): : 174 - 175
  • [33] Matrix metalloproteinase-2: Not (just) a "hero" of the past
    Henriet, Patrick
    Emonard, Herve
    BIOCHIMIE, 2019, 166 : 223 - 232
  • [34] Inhibition of matrix metalloproteinase-2 by PARP inhibitors
    Nicolescu, Adrian C.
    Holt, Andrew
    Kandasamy, Arulmozhi D.
    Pacher, Pal
    Schulz, Richard
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (04) : 646 - 650
  • [35] Ceruloplasmin binds and inactivates matrix metalloproteinase-2
    Thompson, Michael W.
    FASEB JOURNAL, 2012, 26
  • [36] Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection
    Bencsik, Peter
    Kupai, Krisztina
    Goerbe, Aniko
    Kenyeres, Eva
    Varga, Zoltan V.
    Paloczi, Janos
    Gaspar, Renata
    Kovacs, Laszlo
    Weber, Lutz
    Takacs, Ferenc
    Hajdu, Istvan
    Fabo, Gabriella
    Cseh, Sandor
    Barna, Laszlo
    Csont, Tamas
    Csonka, Csaba
    Dorman, Gyoergy
    Ferdinandy, Peter
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [37] Polymorphisms in matrix metalloproteinase-2 are associated with increased risk of developing thoracic aortic aneurysm.
    Guo, D
    Yin, Z
    Qi, Y
    Estrera, A
    Safi, H
    Shete, S
    King, T
    Milewicz, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 590 - 590
  • [38] Effect of abdominal aoric aneurysm repair on circulating levels of matrix metalloproteinase-2 and-9
    Makowski, GS
    Ramsby, ML
    Vasquez, J
    Drezner, AD
    CLINICAL CHEMISTRY, 2005, 51 : A87 - A88
  • [39] Control of matrix metalloproteinase-2 activity by phosphorylation
    Sariahmetoglu, M
    Leon, H
    Sawicka, J
    Sawicki, G
    Schulz, R
    FASEB JOURNAL, 2004, 18 (05): : A1115 - A1115
  • [40] The Role of Matrix Metalloproteinase-2 in Vitiligo Treatment
    Celik, Heybet Ozkaya
    Yilmazer, Demet
    Atacan, Damla
    Eskioglu, Fatma
    Alper, Murat
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2010, 44 (04): : 216 - 219